Security key
88025U109
10x Genomics, Inc. - Class A Common Stock, $0.00001 par value per share (TXG)
CUSIP: 88025U109
Q3 2020 13F Holders as of 30 Sep 2020
- Security type / class
- Equity / Class A Common Stock, $0.00001 par value per share
- Total 13F shares
- 69,088,795
- Total 13F value
- $8,545,655,879
- Share change
- +7,982,029
- Put/Call ratio
- 26%
- SEC-reported price per share
- $124.68
- Number of holders
- 215
- Value change
- +$1,071,434,021
- Number of buys
- 166
- Number of sells
- 49
- Shares outstanding
- 116,858,154
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2020
Institutions
215
Top holders
10
TXG full security history
Ownership snapshot
Full 13F holder table
10x Genomics, Inc. SEC filings
10x Genomics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of TXG - 10x Genomics, Inc. - Class A Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Venrock Management VI, LLC
Disclosed value leader
Venrock Management VI, LLC
Comparable rows
15/15
Latest evidence
30 Jun 2020
13F
Lead comparable stake: 8%
Showing 1-6 of 15 holder rows.
Quick read
Venrock Management VI, LLC leads the comparable SEC ownership view at 8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Venrock Management VI, LLC's linked filing trail.
Comparable ownership
Top 5
Venrock Management VI, LLC
8%
MORGAN STANLEY
7%
FMR LLC
6.2%
Foresite Capital Management II, LLC
4.7%
VANGUARD GROUP INC
3.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Venrock Management VI, LLC |
13F
Company
|
8%
|
$834,562,000
9,344,551 shares
|
— | 30 Jun 2020 |
| MORGAN STANLEY |
13F
Company
|
7%
|
$734,253,000
8,221,397 shares
|
— | 30 Jun 2020 |
| FMR LLC |
13F
Company
|
6.2%
|
$641,998,000
7,188,421 shares
|
— | 30 Jun 2020 |
| Foresite Capital Management II, LLC |
13F
Company
|
4.7%
|
$491,520,000
5,503,528 shares
|
— | 30 Jun 2020 |
| VANGUARD GROUP INC |
13F
Company
|
3.4%
|
$353,469,000
3,957,771 shares
|
— | 30 Jun 2020 |
| Foresite Capital Management I, LLC |
13F
Company
|
3%
|
$312,585,000
3,500,000 shares
|
— | 30 Jun 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
215
Shares
69,088,795
Rows available
215
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
141
Q3 2020 holders
215
Holder diff
74
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 value | Q3 2020 value | Value change | Value Chg % |
|---|